Seebri Neohaler

Active Ingredient(s): Glycopyrrolate
FDA Approved: * October 29, 2015
Category: Lungs (Pulmonary)

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has few to no central effects. It is available in oral, intravenous, topical, and inhaled forms. It is a synthetic quaternary ammonium compound. The cation, which is the active moiety, is called glycopyrronium (INN)[1] or glycopyrrolate (USAN). In June 2018, glycopyrronium was approved by the FDA to treat excessive underarm sweating,... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Seebri Neohaler 15.6 ug/1 Respiratory (Inhalation) Capsule
NDC: 0078-0662
Novartis Pharmaceuticals Corporation
Seebri Neohaler 15.6 ug/1 Respiratory (Inhalation) Capsule
NDC: 63402-815
Sunovion Pharmacueticals Inc.

Related Brands

Drugs with the same active ingredients

Popular Topics

seebri breezhaler

Iv recently been diagnosed with copd ,im 65yr old male fev 1. 54%. On opioid s for pain management neck problem ,taking ...

Does Anyone Know How To Get A Drug Called Seebri Breez Inhaler From Canada

Does anyone know how to get the new inhaler for COPD called Seeri Breez from Canada....